« Back to Record
Citation APA

Matikas, A., Naume, B., Wildiers, H., Sonke, G. G., Dieci, M. V., Karakatsanis, A., Andersson, A., Barnekow, E., Kessler, L. E., Einbeigi, Z., Killander, F., Linderholm, B. B., Schiza, A., Valachis, A., Nearchou, A., Engebraaten, O., Porojnicu, A., Soland, M. H., Mannsåker, B., Raj, S. X., Blix, E. S., Nordstrand, C. S., Lambertini, M., Vernieri, C., Punie, K., Sotiriou, C., Bergh, J., Villacampa, G., Zouzos, A., Hellström, M., Hartman, J., & Foukakis, T. (2025). Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE. BMJ open, 15(8), e102626. doi:10.1136/bmjopen-2025-102626


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/398092

Matikas, A., Naume, B., Wildiers, H., Sonke, G. G., Dieci, M. V., Karakatsanis, A., Andersson, A., Barnekow, E., Kessler, L. E., Einbeigi, Z., Killander, F., Linderholm, B. B., Schiza, A., Valachis, A., Nearchou, A., Engebraaten, O., Porojnicu, A., Soland, M. H., Mannsåker, B., Raj, S. X., Blix, E. S., Nordstrand, C. S., Lambertini, M., Vernieri, C., Punie, K., Sotiriou, C., Bergh, J., Villacampa, G., Zouzos, A., Hellström, M., Hartman, J., & Foukakis, T. (2025). Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE. BMJ open, 15(8), e102626. doi:10.1136/bmjopen-2025-102626